Home › MASTEK › Filing
🔔 Get instant alerts when MASTEK files quarterly results on BSE Start free trial →
Mastek Limited (MASTEK)

Press Release

Filed: 23 Oct 2026, 15:59 IST Exchange: NSE Category: Financial Results — Press Release
Press Release - Q2FY27 - Revenue 1,018.7 Cr +3.4% q-o-q, +8.3% y-o-y; EBITDA margin 14.4%, -109 bps q-o-q - Signed 53 new AI deals in Q2 contributing ~45% of order book; strong AI-led growth - UK & Europe revenue +4.1% q-o-q; North America order book growth strong - EBITDA impacted by annual increments; focus on AI productivity and cost discipline - 12-month order backlog Rs 2,742.8 Cr, +10.4% y-o-y in INR - Cash balance Rs 930.6 Cr; net cash added despite dividend and loan repayments - CEO: "Leading Mastek into AI transformational company in select verticals" - CFO: "Strong quarter despite macro challenges; improving cash position for investments"
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 MASTEK — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
⚡
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add MASTEK to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Mastek Limited

Important. The summary above is generated automatically from Mastek Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.